Dr. Noam Auslander's AI Development for Cancer Research
Dr. Noam Auslander, an Assistant Professor at The Wistar Institute, has been awarded the 2022 Michelson Prizes: Next Generation Grant for her work in artificial intelligence and immunology.
Auslander is developing machine learning methods to understand the genetic and infectious factors that drive cancer evolution, identifying patterns that can improve cancer diagnosis and treatment.
Her approach involves detecting microbial expression in cancer and immune diseases, which has the potential to improve vaccine and immunotherapy development.
The $150,000 grant will allow Auslander to pursue more challenging directions, including searching for new microbes in tumors, and exploring new areas of uncertain territory. Auslander's work has the potential to shape future research and career paths, improving patient outcomes and shaping the future of cancer diagnosis and treatment.
Image courtesy of The Wistar Institute.
About Michelson Prizes:
The Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.
The 2023 Michelson Prizes will be looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. For more information about the prizes, please visit https://www.michelsonmedicalresearch.org/michelson-prizes-next-generation.